Correlation between CCL4 gene polymorphisms and clinical aspects of breast cancer

Gui Nv Hu, Huey En Tzeng, Po Chun Chen, Chao Qun Wang, Yong Ming Zhao, Yan Wang, Chen Ming Su, Chih Hsin Tang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Breast cancer is a major cause of cancer mortality amongst women. Chemokine (C-C motif) ligand 4 is encoded by the CCL4 gene; specific CCL4 gene polymorphisms are related to the risks and prognoses of various diseases. In this study, we examined whether CCL4 gene single nucleotide polymorphisms (SNPs) predict the risk and progression of breast cancer. Between 2014 and 2016, we recruited 314 patients diagnosed with breast cancer and a cohort of 209 healthy participants (controls) without a history of cancer. Genotyping of the CCL4 rs1634507, rs10491121 and rs1719153 SNPs revealed no significant between-group differences for these polymorphisms. However, amongst luminal A and luminal B subtypes, compared with patients with the AA genotype, those carrying the AG genotype at SNP rs10491121 were less likely to develop lymph node metastasis. In addition, compared with AA carriers, those carrying the AG + GG genotype at SNP rs10491121 were at lower risk of developing distant metastasis, while the presence of the AT genotype at SNP rs1719153 increased the likelihood of pathologic grade (G3 or G4) disease. Variations in the CCL4 gene may help to predict breast cancer progression and metastasis.

Original languageEnglish
Pages (from-to)1179-1186
Number of pages8
JournalInternational Journal of Medical Sciences
Volume15
Issue number11
DOIs
Publication statusPublished - Jul 30 2018

Fingerprint

Single Nucleotide Polymorphism
Breast Neoplasms
Genotype
Genes
Neoplasm Metastasis
CC Chemokines
Neoplasms
Healthy Volunteers
Lymph Nodes
Ligands
Mortality

Keywords

  • Breast cancer
  • Chemokine C-C motif ligand 4 (CCL4)
  • Genotype
  • Single nucleotide polymorphism

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Correlation between CCL4 gene polymorphisms and clinical aspects of breast cancer. / Hu, Gui Nv; Tzeng, Huey En; Chen, Po Chun; Wang, Chao Qun; Zhao, Yong Ming; Wang, Yan; Su, Chen Ming; Tang, Chih Hsin.

In: International Journal of Medical Sciences, Vol. 15, No. 11, 30.07.2018, p. 1179-1186.

Research output: Contribution to journalArticle

Hu, Gui Nv ; Tzeng, Huey En ; Chen, Po Chun ; Wang, Chao Qun ; Zhao, Yong Ming ; Wang, Yan ; Su, Chen Ming ; Tang, Chih Hsin. / Correlation between CCL4 gene polymorphisms and clinical aspects of breast cancer. In: International Journal of Medical Sciences. 2018 ; Vol. 15, No. 11. pp. 1179-1186.
@article{388ca2f15d5d441a9c08057882a1ea32,
title = "Correlation between CCL4 gene polymorphisms and clinical aspects of breast cancer",
abstract = "Breast cancer is a major cause of cancer mortality amongst women. Chemokine (C-C motif) ligand 4 is encoded by the CCL4 gene; specific CCL4 gene polymorphisms are related to the risks and prognoses of various diseases. In this study, we examined whether CCL4 gene single nucleotide polymorphisms (SNPs) predict the risk and progression of breast cancer. Between 2014 and 2016, we recruited 314 patients diagnosed with breast cancer and a cohort of 209 healthy participants (controls) without a history of cancer. Genotyping of the CCL4 rs1634507, rs10491121 and rs1719153 SNPs revealed no significant between-group differences for these polymorphisms. However, amongst luminal A and luminal B subtypes, compared with patients with the AA genotype, those carrying the AG genotype at SNP rs10491121 were less likely to develop lymph node metastasis. In addition, compared with AA carriers, those carrying the AG + GG genotype at SNP rs10491121 were at lower risk of developing distant metastasis, while the presence of the AT genotype at SNP rs1719153 increased the likelihood of pathologic grade (G3 or G4) disease. Variations in the CCL4 gene may help to predict breast cancer progression and metastasis.",
keywords = "Breast cancer, Chemokine C-C motif ligand 4 (CCL4), Genotype, Single nucleotide polymorphism",
author = "Hu, {Gui Nv} and Tzeng, {Huey En} and Chen, {Po Chun} and Wang, {Chao Qun} and Zhao, {Yong Ming} and Yan Wang and Su, {Chen Ming} and Tang, {Chih Hsin}",
year = "2018",
month = "7",
day = "30",
doi = "10.7150/ijms.26771",
language = "English",
volume = "15",
pages = "1179--1186",
journal = "International Journal of Medical Sciences",
issn = "1449-1907",
publisher = "Ivyspring International Publisher",
number = "11",

}

TY - JOUR

T1 - Correlation between CCL4 gene polymorphisms and clinical aspects of breast cancer

AU - Hu, Gui Nv

AU - Tzeng, Huey En

AU - Chen, Po Chun

AU - Wang, Chao Qun

AU - Zhao, Yong Ming

AU - Wang, Yan

AU - Su, Chen Ming

AU - Tang, Chih Hsin

PY - 2018/7/30

Y1 - 2018/7/30

N2 - Breast cancer is a major cause of cancer mortality amongst women. Chemokine (C-C motif) ligand 4 is encoded by the CCL4 gene; specific CCL4 gene polymorphisms are related to the risks and prognoses of various diseases. In this study, we examined whether CCL4 gene single nucleotide polymorphisms (SNPs) predict the risk and progression of breast cancer. Between 2014 and 2016, we recruited 314 patients diagnosed with breast cancer and a cohort of 209 healthy participants (controls) without a history of cancer. Genotyping of the CCL4 rs1634507, rs10491121 and rs1719153 SNPs revealed no significant between-group differences for these polymorphisms. However, amongst luminal A and luminal B subtypes, compared with patients with the AA genotype, those carrying the AG genotype at SNP rs10491121 were less likely to develop lymph node metastasis. In addition, compared with AA carriers, those carrying the AG + GG genotype at SNP rs10491121 were at lower risk of developing distant metastasis, while the presence of the AT genotype at SNP rs1719153 increased the likelihood of pathologic grade (G3 or G4) disease. Variations in the CCL4 gene may help to predict breast cancer progression and metastasis.

AB - Breast cancer is a major cause of cancer mortality amongst women. Chemokine (C-C motif) ligand 4 is encoded by the CCL4 gene; specific CCL4 gene polymorphisms are related to the risks and prognoses of various diseases. In this study, we examined whether CCL4 gene single nucleotide polymorphisms (SNPs) predict the risk and progression of breast cancer. Between 2014 and 2016, we recruited 314 patients diagnosed with breast cancer and a cohort of 209 healthy participants (controls) without a history of cancer. Genotyping of the CCL4 rs1634507, rs10491121 and rs1719153 SNPs revealed no significant between-group differences for these polymorphisms. However, amongst luminal A and luminal B subtypes, compared with patients with the AA genotype, those carrying the AG genotype at SNP rs10491121 were less likely to develop lymph node metastasis. In addition, compared with AA carriers, those carrying the AG + GG genotype at SNP rs10491121 were at lower risk of developing distant metastasis, while the presence of the AT genotype at SNP rs1719153 increased the likelihood of pathologic grade (G3 or G4) disease. Variations in the CCL4 gene may help to predict breast cancer progression and metastasis.

KW - Breast cancer

KW - Chemokine C-C motif ligand 4 (CCL4)

KW - Genotype

KW - Single nucleotide polymorphism

UR - http://www.scopus.com/inward/record.url?scp=85051115835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051115835&partnerID=8YFLogxK

U2 - 10.7150/ijms.26771

DO - 10.7150/ijms.26771

M3 - Article

AN - SCOPUS:85051115835

VL - 15

SP - 1179

EP - 1186

JO - International Journal of Medical Sciences

JF - International Journal of Medical Sciences

SN - 1449-1907

IS - 11

ER -